Hoodline

FDA Issues Nationwide Recall of 20,000 Bottles of Triglyceride Medication Due to Oxidation Concerns

The FDA announced a recall of over 20,000 bottles of a triglyceride medication due to an oxidation issue that may lead to ...

20,000 bottles of triglycerides medicine recalled nationwide: FDA

NEW YORK (PIX11) – Over 20,000 bottles of medicine used to treat high triglycerides are being voluntarily recalled, according ...
EurekAlert!

A simple supplement improves survival in patients with a new type of heart disease

Targeting cardiomyocyte steatosis cures heart failure: Heart failure is a pandemic in the aging population. Targeting myocardial long-chain triglyceride in lipid droplets by another triglyceride, ...
MedPage Today

Triglyceride-Lowering Drug Gets FDA Nod for Rare Genetic Disorder

The FDA approved plozasiran (Redemplo) for the reduction of triglycerides in people with familial chylomicronemia syndrome (FCS), the agency announced. The small interfering RNA (siRNA) therapy, ...
Medscape

Fenofibrate: Effective in Children With High Triglycerides?

Fenofibrate may be an effective treatment option in children with hypertriglyceridemia, in whom lower levels of triglycerides ...

Peer-Reviewed Clinical Study Shows Ruby-O® Balance Achieves Triglyceride Response at Lower Omega-3 Dose

The study evaluates how omega-3 delivery architecture influences triglyceride outcomes and omega-3 incorporation in ...
WebMD

Tryngolza: The First Treatment for Familial Chylomicronemia Syndrome

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that causes very high triglyceride levels in the body. Tryngolza (olezarsen) was approved in 2024 and is the first and only ...